Genpact Limited Stock Buy Hold or Sell Recommendation

G Stock  USD 30.95  0.48  1.53%   
Taking into account the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Genpact Limited is 'Strong Hold'. Macroaxis provides Genpact buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Genpact positions.
Check out Genpact Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Genpact and provide practical buy, sell, or hold advice based on investors' constraints. Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Execute Genpact Buy or Sell Advice

The Genpact recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Genpact Limited. Macroaxis does not own or have any residual interests in Genpact Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Genpact's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell GenpactBuy Genpact
Strong Hold

Market Performance

Very WeakDetails


Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation


Odds Of Distress

Very LowDetails

Economic Sensitivity

Almost mirrors the marketDetails

Investor Sentiment


Analyst Consensus


Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Genpact Limited has a Risk Adjusted Performance of (0.04), Jensen Alpha of (0.1), Total Risk Alpha of (0.08) and Treynor Ratio of (0.11)
Our investment recommendation module can be used to complement Genpact Limited trade recommendations provided by average analyst sentiment. It analyzes the entity's potential to grow using fundamental, technical, data market data available at the time. To make sure Genpact Limited is not overpriced, please check out all Genpact fundamentals, including its number of shares shorted, ebitda, current ratio, as well as the relationship between the price to sales and cash per share . Given that Genpact Limited has a price to earning of 28.59 X, we strongly advise you to confirm Genpact Limited market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Genpact Trading Alerts and Improvement Suggestions

Genpact Limited generated a negative expected return over the last 90 days
Genpact Limited is unlikely to experience financial distress in the next 2 years
Over 98.0% of the company shares are owned by institutional investors
Latest headline from Deutsche Bank reaffirms hold on Genpact shares amid uncertainties in GenAI impact

Genpact Returns Distribution Density

The distribution of Genpact's historical returns is an attempt to chart the uncertainty of Genpact's future price movements. The chart of the probability distribution of Genpact daily returns describes the distribution of returns around its average expected value. We use Genpact Limited price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Genpact returns is essential to provide solid investment advice for Genpact.
Mean Return
Value At Risk
Potential Upside
Standard Deviation
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Genpact historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Genpact Stock Institutional Investors

Franklin Resources Inc2024-03-31
3.6 M
Geode Capital Management, Llc2024-03-31
3.1 M
Capital Research & Mgmt Co - Division 32024-03-31
3.1 M
Dimensional Fund Advisors, Inc.2024-03-31
2.5 M
Nordea Investment Mgmt Bank Demark A/s2024-03-31
2.4 M
Morgan Stanley - Brokerage Accounts2024-03-31
2.2 M
Causeway Capital Management Llc2024-03-31
Norges Bank2023-12-31
Amvescap Plc.2024-03-31
Blackrock Inc2024-03-31
20.1 M
Fmr Inc2024-03-31
19.7 M
Note, although Genpact's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Genpact Cash Flow Accounts

201920202021202220232024 (projected)
Change In Cash98.7M213.3M219.0M(252.7M)(63.1M)(59.9M)
Free Cash Flow319.1M503.9M637.0M389.3M432.0M270.0M
Other Non Cash Items(26.0M)48.4M(2.6M)59.6M18.2M16.4M
Capital Expenditures108.8M80.4M57.2M54.4M58.8M77.3M
Net Income304.9M308.3M369.4M353.4M631.3M662.8M
End Period Cash Flow467.1M680.4M899.5M646.8M583.7M472.4M
Change To Netincome39.8M65.4M67.4M83.8M96.3M101.1M
Dividends Paid64.7M74.2M80.5M91.8M100.0M184.3M
Change Receivables(122.0M)42.5M(11.8M)(112.3M)(101.1M)(96.1M)
Net Borrowings138.7M145.4M52.1M(233.0M)(209.7M)(199.3M)

Genpact Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Genpact or IT Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Genpact's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Genpact stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over NYSE Composite
Beta against NYSE Composite0.95
Overall volatility
Information ratio -0.07

Genpact Volatility Alert

Genpact Limited exhibits very low volatility with skewness of 0.15 and kurtosis of 0.38. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Genpact's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Genpact's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Genpact Fundamentals Vs Peers

Comparing Genpact's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Genpact's direct or indirect competition across all of the common fundamentals between Genpact and the related equities. This way, we can detect undervalued stocks with similar characteristics as Genpact or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Genpact's fundamental indicators could also be used in its relative valuation, which is a method of valuing Genpact by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Genpact to competition
FundamentalsGenpactPeer Average
Return On Equity0.3-0.31
Return On Asset0.0861-0.14
Profit Margin0.14 %(1.27) %
Operating Margin0.14 %(5.51) %
Current Valuation6.71 B16.62 B
Shares Outstanding179.98 M571.82 M
Shares Owned By Insiders1.04 %10.09 %
Shares Owned By Institutions98.08 %39.21 %
Number Of Shares Shorted4.54 M4.71 M
Price To Earning28.59 X28.72 X
Price To Book2.50 X9.51 X
Price To Sales1.26 X11.42 X
Revenue4.48 B9.43 B
Gross Profit1.54 B27.38 B
EBITDA630.86 M3.9 B
Net Income631.25 M570.98 M
Cash And Equivalents646.76 M2.7 B
Cash Per Share2.53 X5.01 X
Total Debt1.5 B5.32 B
Debt To Equity1.04 %48.70 %
Current Ratio1.58 X2.16 X
Book Value Per Share12.80 X1.93 K
Cash Flow From Operations490.81 M971.22 M
Short Ratio2.69 X4.00 X
Earnings Per Share3.48 X3.12 X
Price To Earnings To Growth1.70 X4.89 X
Target Price37.2
Number Of Employees131 K18.84 K
Market Capitalization5.66 B19.03 B
Total Asset4.81 B29.47 B
Retained Earnings1.09 B9.33 B
Working Capital573.58 M1.48 B
Note: Disposition of 1000 shares by N Tyagarajan of Genpact at 33.17 subject to Rule 16b-3 [view details]

Genpact Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Genpact . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Genpact Buy or Sell Advice

When is the right time to buy or sell Genpact Limited? Buying financial instruments such as Genpact Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Total Stockholder Equity1.9B1.8B2.2B1.4B
Total Assets5.0B4.6B4.8B3.1B

Use Investing Ideas to Build Portfolios

In addition to having Genpact in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run SPAC Thematic Idea Now

SPAC Theme
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Genpact Stock

When determining whether Genpact Limited is a strong investment it is important to analyze Genpact's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Genpact's future performance. For an informed investment choice regarding Genpact Stock, refer to the following important reports:
Check out Genpact Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Data Processing & Outsourced Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
Dividend Share
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.